FIELD: medicine. SUBSTANCE: method involves adding synthetic tetrapeptide taphcin at a dose of 0.2-20.0 mcg per 1 mouse to mycobacterial mixture in applying intraplantar administration method in infecting experimental animals with leprosy mycobacteria at a dose of 1×104 microbe bodies per 1 mouse. EFFECT: accelerated increase of mycobacteria accumulation and development of leprosy. 5 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF LEPROUS INFECTION MODELLING | 1995 |
|
RU2102482C1 |
METHOD OF IMMUNOPROPHYLAXIS OF EXPERIMENTAL LEPROSY INFECTION | 1996 |
|
RU2135196C1 |
METHOD FOR TREATING EXPERIMENTAL LEPROUS INFECTION | 1999 |
|
RU2188003C2 |
METHOD OF SIMULATING LEPRA | 0 |
|
SU1439665A1 |
METHOD OF SIMULATING MACROPHAGE DEFECT | 1994 |
|
RU2105352C1 |
METHOD OF TREATING EXPERIMENTAL LEPROUS INFECTION | 2011 |
|
RU2467742C1 |
METHOD FOR LONG-TERM STORAGE OF LEPROSY MYCOBACTERIA | 2019 |
|
RU2737149C1 |
METHOD OF ESTIMATION OF LEPROSY RELAPSE RISK GROUP | 1993 |
|
RU2082979C1 |
METHOD FOR TREATING EXPERIMENTAL LEPROUS INFECTION | 2006 |
|
RU2322991C1 |
LIQUID CULTURE MEDIUM FOR CULTURING MYCOBACTERIA FROM LEPROMA FROM LEPROSY PATIENTS | 2009 |
|
RU2403282C1 |
Authors
Dates
1997-12-10—Published
1993-04-26—Filed